A new multinational study from the INTERCOVID Consortium, including Ann & Robert H. Lurie Children's Hospital of Chicago, has ...

Del-desiran (also known as AOC1001) is an antibody-oligonucleotide conjugate comprised of a DMPK small interfering RNA (siRNA ...

The study involved 550 healthy U.S. adults ages 18 to 75 who received either the experimental combo vaccine and a placebo or ...

COVID-19 vaccine hesitancy in England decreased from 8.8% to 2.2%, yet mistrust-driven attitudes remained a strong barrier to uptake.

Viral mimic systems and other tech platforms could enable local testing of vaccine candidates and antiviral therapies. This is important in the context of low-resourced health settings, Africa's focus ...

Moderna's new mRNA vaccine targets both flu and COVID-19, showing strong immune responses in trials, while non-celiac gluten ...

The University no longer operates any Biosafety Level 3 laboratories following changes to SARS-CoV-2 research containment ...

COVID-19 severity appears to be declining among hospitalized children as the Omicron variant continues to evolve.

Intranasal boosting after prior intramuscular COVID vaccination induced strong mucosal IgA responses in a small human cohort. These antibodies showed markedly enhanced neutralising activity against ...

aNational Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, ...